Factors associated with a reduced potential for tobacco use are called
A. safety factors.
B. danger factors.
C. risk factors.
D. protective factors.
Answer: D
You might also like to view...
Identify which of the following statements is true regarding the transporter associated with antigen processing (TAP)
a. TAP is a homodimer composed of two identical subunits. b. TAP transports proteasome-derived peptides from the cytosol directly to the lumen of the Golgi apparatus. c. TAP is an ATP-dependent, membrane-bound transporter. d. Peptides transported by TAP bind preferentially to MHC class II molecules. e. TAP deficiency causes a type of bare lymphocytes syndrome resulting in severely depleted levels of MHC class II molecules on the surface of antigen-presenting cells.
A public health nurse is conducting a health promotion campaign under the auspices of the local community center
Which of the following measures that the nurse is promoting are likely to influence the participants' risk of hypercoagulability disorders? Select all that apply. A) Smoking cessation B) Blood glucose screening C) Daily dose of vitamins with minerals D) Cholesterol screening and management E) Eliminating consumption of all alcoholic beverages
A client with a history of antiphospholipid syndrome presents to the emergency department. Which of the following complaints lead the nurse to suspect the client is experiencing a complication related to the syndrome? Select all that apply
A) Swelling in the right calf with redness and tenderness B) Having respiratory symptoms like shortness of breath and chest pain C) Have developed a cough that produced some bloody sputum D) Developed a headache that has lasted for 3 days now E) Having trouble making "water" and has pain in the lower abdomen and groin
What three key brain chemicals are released during the tend-and-befriend response?
A) serotonin, adrenaline, and cortisol B) dopamine, ACTH, and cortisol C) oxytocin, dopamine, and serotonin D) ACTH, adrenaline, and noradrenaline E) ?oxytocin, ACTH, and insulin